Principal Financial Group
GH icon

Principal Financial Group’s Guardant Health GH Stock Holding History

Principal Financial Group’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.8M Buy
185,430
+584
+0.3% +$63.5K 0.01% 796
2026
Q1 		$17.1M Buy
184,846
+31,064
+20% +$3.12M 0.01% 1019
2025
Q4 		$15.7M Sell
153,782
-22,734
-13% -$2.03M 0.01% 1037
2025
Q3 		$11M Sell
176,516
-86,006
-33% -$4.68M 0.01% 1230
2025
Q2 		$13.7M Sell
262,522
-235,607
-47% -$10.5M 0.01% 1082
2025
Q1 		$21.2M Buy
498,129
+488,043
+4,839% +$21.1M 0.01% 789
2024
Q4 		$308K Sell
10,086
-880
-8% -$24.8K ﹤0.01% 2030
2024
Q3 		$252K Sell
10,966
-4,976
-31% -$141K ﹤0.01% 2063
2024
Q2 		$460K Sell
15,942
-212,273
-93% -$4.94M ﹤0.01% 1979
2024
Q1 		$4.71M Buy
228,215
+215,170
+1,649% +$4.61M ﹤0.01% 1589
2023
Q4 		$353K Buy
13,045
+1,240
+11% +$32.5K ﹤0.01% 2025
2023
Q3 		$350K Sell
11,805
-1,323
-10% -$46.5K ﹤0.01% 2022
2023
Q2 		$470K Buy
13,128
+2,718
+26% +$78.1K ﹤0.01% 1970
2023
Q1 		$244K Sell
10,410
-1,946
-16% -$55.6K ﹤0.01% 2134
2022
Q4 		$336K Sell
12,356
-10,817
-47% -$495K ﹤0.01% 2074
2022
Q3 		$1.25M Sell
23,173
-1,710
-7% -$87.8K ﹤0.01% 1805
2022
Q2 		$1M Buy
24,883
+4,325
+21% +$214K ﹤0.01% 1919
2022
Q1 		$1.36M Sell
20,558
-1,343
-6% -$91.9K ﹤0.01% 1921
2021
Q4 		$2.19M Sell
21,901
-7,564
-26% -$782K ﹤0.01% 1843
2021
Q3 		$3.68M Sell
29,465
-3,756
-11% -$446K ﹤0.01% 1770
2021
Q2 		$4.13M Buy
33,221
+1,696
+5% +$228K ﹤0.01% 1764
2021
Q1 		$4.81M Buy
31,525
+952
+3% +$144K ﹤0.01% 1678
2020
Q4 		$3.94M Buy
30,573
+1,343
+5% +$155K ﹤0.01% 1648
2020
Q3 		$3.27M Sell
29,230
-2,107
-7% -$193K ﹤0.01% 1614
2020
Q2 		$2.54M Buy
31,337
+17,055
+119% +$1.37M ﹤0.01% 1646
2020
Q1 		$994K Buy
14,282
+604
+4% +$46.4K ﹤0.01% 1733
2019
Q4 		$1.07M Buy
13,678
+350
+3% +$25.2K ﹤0.01% 1820
2019
Q3 		$851K Sell
13,328
-5,191
-28% -$457K ﹤0.01% 1850
2019
Q2 		$1.6M Buy
+18,519
New +$1.41M ﹤0.01% 1761

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Principal Financial Group's GH Position: Q2 2026 in Review

Principal Financial Group increased its Guardant Health (GH) stake by 0.32% in Q2 2026, buying an estimated $63.5K and bringing the position to 185,430 shares worth $27.8M. The position accounts for 0.01% of the portfolio, ranked #796.

Principal Financial Group first reported a position in GH in Q2 2019 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Principal Financial Group held 185,430 shares of Guardant Health worth $27.8M as of Q2 2026.
  • Principal Financial Group bought 584 Guardant Health shares in Q2 2026, an estimated $63.5K.
  • Guardant Health made up 0.01% of Principal Financial Group's portfolio in Q2 2026, its #796 holding.
  • Principal Financial Group first reported a position in Guardant Health in Q2 2019 and has held it in 29 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.